Alkermes plc (ALKS) Q1 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Greetings and welcome to Alchemy's first quarter 2025 financial results conference call. My name is Maria and I'll be the operator for today's call. All participant lines will be placed on mute to prevent background noise. If you should require an operator assistance during the call, please press star zero from your telephone keypad. Please note that this conference is being recorded. I will now turn the call over to Sandra Coombs, Senior Vice President of Investor Relations and Corporate Affairs. Sandy, you may now begin. Good morning. Welcome to the Alkermes PLC conference call to discuss our financial results and business update for the quarter ended March 31st, 2025. With me today are Richard Pops, our CEO, Todd Nichols, our Chief Commercial Officer, Blair Jackson, our Chief Operating Officer, and Dr. Craig Hopkinson, our Chief Medical Officer. A slide presentation along with our press release, related financial tables, and reconciliations of the gap to non-gap financial measures that we'll discuss today are available on the investor section of Alkermes.com. We believe the non-GAAP financial results in conjunction with the GAAP results are useful in understanding the ongoing economics of our business. Our discussions during this conference call will include forward-looking statements. Actual results could differ materially from these forward-looking statements. Please see slide two of the accompanying presentation, our press release issued this morning, and our most recent annual and quarterly reports filed with the SEC For important risk factors, the codes cause our actual results to differ materially from those expressed or implied in the forward-looking statement. We undertake no obligation to update or revise the information provided on this call or in the ac...